Imperial Oil Limited Common Stock vs Eli Lilly And Co — how do they compare? Imperial Oil Limited Common Stock trades at $129.6 (market cap $62.22B), while Eli Lilly And Co trades at $1,213.95 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 16.7× Imperial Oil Limited Common Stock's market cap, and Imperial Oil Limited Common Stock pays the higher dividend (1.9%). Which is the better fit depends on your goals.
| IMO | LLY | |
|---|---|---|
Market Cap | $62.22B | $1.04T |
Volume | 560,544 | 1,843,375 |
Sector | Energy | Health |
52-Week High | $138.33 | $1.28K |
52-Week Low | $83.72 | $799.57 |
Enterprise Value | $63.13B | $1.09T |
Dividend Yield | 1.9% | 0.59% |
Typical Hold Time | — | 94 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,211.40, up 2.43% today, with a bullish technical outlook and strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $8.38 surpassing the $6.40 estimate. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Positive news flow highlights pipeline advancements in weight-loss drugs, including EloraTZP's promising trial results.
Outlook remains positive given dominant market position in obesity and diabetes treatments, with analyst consensus price target of $1,350 implying ~11% upside. Key risks include competitive pressures from Novo Nordisk and regulatory hurdles. Earnings growth and pipeline catalysts support further appreciation, though high valuations warrant monitoring.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Imperial Oil Limited is a Canadian integrated energy company that explores for and produces crude oil and natural gas, operates oil sands projects at Cold Lake, Kearl, and Syncrude, and refines and markets petroleum products under the Esso and Mobil brands. ExxonMobil Corporation holds a majority ownership stake in the company.
Read more on IMO →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →